Nassenstein K, Veit-Haibach P, Stergar H, Gutzeit A, Freudenberg L, Kuehl H, Fischer M, Barkhausen J, Bockisch A, Antoch G
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Germany.
Acta Radiol. 2007 Dec;48(10):1101-8. doi: 10.1080/02841850701581768.
Identification of primary tumor in patients with cervical lymph node metastasis of unknown primary (MUO) has a great impact on therapy approach and potentially on patient prognosis.
To assess the diagnostic accuracy of combined positron emission tomography(PET)/computer tomography (CT) for primary tumor detection in cervical metastases of unknown origin compared to PET, CT, and PET+CT side-by-side evaluation.
39 consecutive patients (eight women, 31 men; mean age 59.9 ± 11.2 years) with MUO were enrolled in this study. PET/CT images were obtained 1 hour after injection of 350 MBq of fluorodeoxyglucose. Oral and intravenous contrast agents were administered in all patients to ensure diagnostic CT data. Fused PET/CT data were evaluated for primary tumor detection. Diagnostic accuracy was calculated and compared with CT alone, PET alone, and side-by-side PET+CT evaluation.Statistical analysis of differences in diagnostic performance between the different imaging procedures was based on the McNemar test.
Fused PET/CT depicted the primary tumor in 11 of 39 (28%) patients. In 28(72%) patients, the primary tumor remained occult. CT revealed the primary in five(13%), PET alone in 10 (26%), and side-by-side evaluation of PET+CT in 10 (26%) of 39 patients. Statistical analysis showed no significant differences between the imaging modalities.
PET, side-by-side PET+CT, and PET/CT revealed similar detection rates for primary tumors in cervical MUO patients. Therefore, cervical metastases of an unknown primary may be assessed with either of these imaging modalities. Detection rates with CT were substantially lower. Thus, inclusion of functional data for assessment of cervical MUO patients must be recommended.
在不明原发灶(MUO)的颈部淋巴结转移患者中,原发肿瘤的识别对治疗方案有重大影响,可能还会影响患者预后。
评估与正电子发射断层扫描(PET)、计算机断层扫描(CT)以及PET + CT并列评估相比,联合正电子发射断层扫描/计算机断层扫描(PET/CT)在检测不明来源颈部转移瘤中原发肿瘤的诊断准确性。
本研究纳入了39例连续的MUO患者(8例女性,31例男性;平均年龄59.9±11.2岁)。在注射350 MBq氟脱氧葡萄糖1小时后获取PET/CT图像。所有患者均口服和静脉注射对比剂以确保获得诊断性CT数据。对融合的PET/CT数据进行原发肿瘤检测评估。计算诊断准确性,并与单独的CT、单独的PET以及PET + CT并列评估进行比较。基于McNemar检验对不同成像程序之间诊断性能的差异进行统计学分析。
融合的PET/CT在39例患者中的11例(28%)中显示出原发肿瘤。在28例(72%)患者中,原发肿瘤仍未被发现。CT在39例患者中的5例(13%)中显示出原发肿瘤,单独的PET在10例(26%)中显示出原发肿瘤,PET + CT并列评估在10例(26%)中显示出原发肿瘤。统计学分析表明成像方式之间无显著差异。
PET、PET + CT并列以及PET/CT在MUO颈部患者中原发肿瘤的检测率相似。因此,这些成像方式中的任何一种都可用于评估不明原发灶的颈部转移瘤。CT的检测率显著更低。因此,建议纳入功能数据来评估MUO颈部患者。